Production (Stage)
Global Medical REIT Inc.
GMRE
$6.20
$0.040.65%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.60M | 34.95M | 34.18M | 34.21M | 35.07M |
| Total Other Revenue | -17.00K | 184.00K | 89.00K | 27.00K | 49.00K |
| Total Revenue | 34.58M | 35.14M | 34.26M | 34.24M | 35.12M |
| Cost of Revenue | 7.59M | 155.00K | -- | -- | 7.38M |
| Gross Profit | 26.99M | 34.98M | 34.26M | 34.24M | 27.73M |
| SG&A Expenses | 4.59M | 15.98M | 12.93M | 12.99M | 5.63M |
| Depreciation & Amortization | 12.76M | 12.56M | 12.53M | 12.83M | 12.90M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.93M | 28.70M | 25.46M | 25.82M | 25.91M |
| Operating Income | 9.65M | 6.44M | 8.80M | 8.42M | 9.20M |
| Income Before Tax | 3.74M | 2.94M | 3.39M | -1.95M | 2.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.74M | 2.94M | 3.39M | -1.95M | 2.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -178.00K | -109.00K | -145.00K | 260.00K | -65.00K |
| Net Income | 3.56M | 2.83M | 3.25M | -1.69M | 2.25M |
| EBIT | 9.65M | 6.44M | 8.80M | 8.42M | 9.20M |
| EBITDA | 22.62M | 19.26M | 21.51M | 21.40M | 22.24M |
| EPS Basic | 0.03 | 0.02 | 0.03 | -0.05 | 0.01 |
| Normalized Basic EPS | 0.02 | -0.01 | 0.01 | 0.02 | 0.02 |
| EPS Diluted | 0.03 | 0.02 | 0.03 | -0.05 | 0.01 |
| Normalized Diluted EPS | 0.02 | -0.01 | 0.01 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 66.87M | 66.84M | 65.74M | 65.59M | 65.57M |
| Average Diluted Shares Outstanding | 66.87M | 66.84M | 65.74M | 65.59M | 65.57M |
| Dividend Per Share | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
| Payout Ratio | 469.91% | 585.34% | 504.25% | -966.67% | 729.26% |